Full donor chimerism by day 30 after allogeneic peripheral blood progenitor cell transplantation is associated with a low risk of relapse in pediatric patients with …

A Lassaletta, M Ramirez, JM Montero… - Leukemia, 2005 - nature.com
Despite the many reports available on chimerism status after allogeneic hematopoietic
transplantation, few studies have focused on chimerism using peripheral blood progenitor …

Recent advances in quantitative chimerism analysis

E Gineikiene, M Stoskus… - Expert review of molecular …, 2009 - Taylor & Francis
Quantitative chimerism analysis is a diagnostic tool used to monitor engraftment kinetics
after allogeneic stem cell transplantation. It reflects the proportion of recipient and donor …

[HTML][HTML] Low-dose decitabine monotherapy reverses mixed chimerism in adult patients after allogeneic hematopoietic stem cell transplantation with myeloablative …

L Wang, LN Wang, JF Zhou, WH Gao, CH Jiang… - Frontiers in …, 2021 - frontiersin.org
T cell mixed chimerism (MC) after allogeneic hematopoietic stem cell transplantation (allo-
HSCT) with myeloablative conditioning for hematological malignancies may indicate …

Relapse assessment following allogeneic SCT in patients with MDS and AML

M Christopeit, N Kröger, T Haferlach, U Bacher - Annals of hematology, 2014 - Springer
Options to pre-emptively treat impending relapse of myelodysplastic syndromes (MDS) and
acute myeloid leukaemia (AML) after allogeneic haematopoietic stem cell transplantation …

[HTML][HTML] FLAMSA-busulfan-melphalan as a sequential conditioning regimen in HLA-matched or haploidentical hematopoietic stem cell transplantation for high-risk …

L Jondreville, D Roos-Weil, M Uzunov… - … and Cellular Therapy, 2021 - Elsevier
Given the poor prognosis of relapsed/refractory myeloid malignancies, the concept of
sequential conditioning before allogeneic hematopoietic stem cell transplantation (allo …

Monitoring of post-transplant remission of childhood malignancies: is there a standard?

P Bader, A Willasch, T Klingebiel - Bone Marrow Transplantation, 2008 - nature.com
Chimerism analysis has become an important tool for the peri-transplant surveillance of
engraftment. It offers the possibility to realize imminent graft rejection and it can serve as an …

Targeted iv BU and fludarabine (ti. v. BU/Flu) provides effective control of AML in adults with reduced toxicity

J Pidala, J Kim, C Anasetti… - Bone marrow …, 2011 - nature.com
Myeloablative doses of BU and fludarabine followed by allogeneic hematopoietic cell
transplantation offer effective therapy for AML. We anticipated that pharmacokinetic targeting …

Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of …

N Imahashi, H Ohashi, S Terakura, K Miyao… - Annals of …, 2015 - Springer
Little is known regarding the chimerism status after reduced-intensity conditioning
transplantation when bone marrow is used as a stem cell source. We prospectively analyzed …

A SYBR green‐based real‐time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients

L Bai, YM Deng, AJ Dodds, S Milliken… - European journal of …, 2006 - Wiley Online Library
Objective: To develop a reliable and rapid real‐time quantitative polymerase chain reaction
(Q‐PCR) method using SYBR green to quantify chimerism in allogeneic haemopoietic stem …

异基因造血干细胞移植后细胞嵌合状态动态监测的临床意义

蒋瑛, 万理萍, 王椿, 颜式可, 高彦荣, 姜杰玲, 杨隽… - 中华血液学杂志, 2008 - cqvip.com
目的研究异基因造血干细胞移植(allo—HSCT) 后各系细胞嵌合状态与移植物植人,
急性移植物抗宿主病(aGVHD), 移植物被排斥和疾病复发的关系. 方法对65 例患者进行allo …